Christi L. Shaw has been appointed chief executive officer of Kite, a Gilead Company, and will become a member of Gilead’s senior leadership team. Ms. Shaw has extensive experience providing commercial, financial, strategic, medical and operations leadership across the biopharmaceutical industry. Ms. Shaw currently serves as senior vice president of Eli Lilly &. Co., and president of Lilly Bio-Medicines. She also serves as a board member of both Avantor, Inc. and the Biotechnology Industr...